Stone Ridge Asset Management’s West Pharmaceutical WST Stock Holding History

Stone Ridge Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,480	Closed	-$1.02M	–	498
2020 Q2	$1.02M	Sell	4,480 -1,514	-25%	-$297K	0.16%	105
2020 Q1	$913K	Sell	5,994 -2,600	-30%	-$400K	0.1%	227
2019 Q4	$1.29M	Buy	8,594 +900	+12%	+$131K	0.08%	326
2019 Q3	$1.09M	Buy	7,694 +1,700	+28%	+$234K	0.07%	378
2019 Q2	$750K	Hold	5,994	–	–	0.04%	534
2019 Q1	$661K	Sell	5,994 -4,700	-44%	-$489K	0.04%	602
2018 Q4	$1.05M	Hold	10,694	–	–	0.06%	396
2018 Q3	$1.32M	Hold	10,694	–	–	0.07%	337
2018 Q2	$1.06M	Buy	10,694 +404	+4%	+$37.2K	0.06%	389
2018 Q1	$909K	Buy	10,290 +1,000	+11%	+$93.5K	0.05%	435
2017 Q4	$917K	Buy	+9,290	New	+$911K	0.06%	434

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Stone Ridge Asset Management's WST Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 4,480 shares — an estimated $1.02M sold.

Stone Ridge Asset Management first reported a position in WST in Q4 2017 and held it in 11 quarters. The position peaked at $1.32M in Q3 2018. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

Stone Ridge Asset Management reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 4,480 West Pharmaceutical shares in Q3 2020, an estimated $1.02M.
Stone Ridge Asset Management first reported a position in West Pharmaceutical in Q4 2017 and held it in 11 quarters.
Stone Ridge Asset Management's West Pharmaceutical position peaked at $1.32M in Q3 2018.
574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.